Rehabilitation Robotics Market Report 2026

Rehabilitation Robotics Market Overview

• Rehabilitation Robotics market size has reached to $1.81 billion in 2025 • Expected to grow to $4.87 billion in 2030 at a compound annual growth rate (CAGR) of 21.7% • Growth Driver: Rising Incidence Of Neurological Disorders Fueling The Growth Of The Market Due To Increasing Demand For Advanced Rehabilitation Solutions • Market Trend: Investments In Robotic-Assisted Neurorehabilitation Center • North America was the largest region and fastest growing region.

What Is Covered Under Rehabilitation Robotics Market?

Rehabilitation robotics is the division of robotics for the development of robots that are used to help people to recover from physical trauma. The rehabilitation robots are automated machines that are designed to improve the movement of disabled persons with impaired physical functioning. The rehabilitation robotics are used to improve the movement of people with impaired physical functioning. The main types of rehabilitation robotics are exoskeleton robots, therapeutic robots, assistive robots, and prosthetic robots. Exoskeleton robots are used as augmentative devices to enhance the physical performance of the body. Exoskeletons are mechanical structures that humans can wear to enhance their strength and endurance. The different rehabilitation robotics patient types include adult and pediatric for parts including lower extremity and upper extremity. The different applications of rehabilitation robotics are gait therapy and limb mobility used by end-users such as rehabilitation centers and hospitals.

What Is The Rehabilitation Robotics Market Growth Forecast?

The rehabilitation robotics market size is expected to see exponential growth in the next few years. It will grow to $4.87 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to increasing investments in smart rehabilitation infrastructure, rising demand for home-based robotic therapy, expansion of aging population rehabilitation needs, growing integration of robotics with digital health platforms, increasing focus on outcome-based rehabilitation. Major trends in the forecast period include increasing deployment of exoskeleton-based rehabilitation systems, rising adoption of robot-assisted gait training, growing use of ai-driven therapy personalization, expansion of upper and lower limb robotic devices, enhanced focus on remote and data-driven rehabilitation.

Global Rehabilitation Robotics Market Segmentation

1) By Type: Exoskeleton Robots, Therapeutic Robots 2) By Patient Type: Adult, Pediatrics 3) By Part: Lower Extremity, Upper Extremity 4) By Application: Gait Therapy, Limb Mobility 5) By End User: Rehabilitation Centers, Hospitals Subsegments: 1) By Exoskeleton Robots: Lower Limb Exoskeletons, Upper Limb Exoskeletons, Full-Body Exoskeletons, Powered and Passive Exoskeletons 2) By Therapeutic Robots: Robotic Rehabilitation Devices for Stroke Patients, Robotic Systems for Gait Training, Robotic Hand Rehabilitation Devices

What Is The Driver Of The Rehabilitation Robotics Market?

The rising instances of strokes, injuries, and neurological diseases are expected to propel the growth of the rehabilitation robotics market going forward. Neurological diseases include disorders of the brain and nervous system such as stroke, traumatic brain injury, and neurodegenerative conditions. The prevalence of these conditions is increasing due to ageing populations, as older adults are more susceptible to strokes, neurodegenerative diseases, and injuries because their brain, nerves, and blood vessels naturally weaken over time. Rehabilitation robotics assist in the recovery from strokes, injuries, and neurological diseases by providing precise, repetitive, and customizable therapeutic exercises that help restore motor function, improve mobility, and accelerate the overall rehabilitation process while reducing the physical strain on therapists. For instance, in October 2024, according to the Alaska Department of Health, a US-based government agency, in 2023, approximately 3,373 people in Alaska sustained traumatic brain injuries (TBI), including both fatal cases and non-fatal injuries that were treated and released from hospitals or emergency departments (EDs). Therefore, the rising instances of strokes, injuries, and neurological diseases are driving demand for advanced rehabilitation solutions, including rehabilitation robotics.

Key Players In The Global Rehabilitation Robotics Market

Major companies operating in the rehabilitation robotics market are Myomo Inc., Bionik Laboratories Corporation, Hocoma AG, Cyberdyne Inc., ReWalk Robotics Ltd., Ekso Bionics Holdings Inc., Rex Bionics Ltd., Tyromotion GmbH, Motek Medical B.V., Reha Technology AG, Rehab-Robotics Company Limited, Kinova Robotics, Fourier Intelligence Co. Ltd., B-Temia Inc., Motorika Medical Ltd., Neofect Co. Ltd., Saebo Inc., Biodex Medical Systems Inc., InMotion LLC, RSL Steeper Group Ltd., AlterG Inc., Woodway GmbH, ABILITY Switzerland AG, Focal Meditech BV, SynTouch LLC, Touch Bionics Inc.

Global Rehabilitation Robotics Market Trends and Insights

Major companies operating in the rehabilitation robotics market are focusing on developing innovative solutions advanced robotic-assisted neurorehabilitation systems to enhance patient recovery and improve functional independence. Robotic-assisted neurorehabilitation systems are specialized medical devices that support individuals recovering from neurological injuries, enabling them to regain mobility and perform rehabilitation exercises more effectively. For instance, in May 2024, Amrita Hospitals, an India-based healthcare provider, launched a robotic gait trainer system designed to transform rehabilitation for patients with brain and spinal injuries. The system assists patients in walking longer distances with greater independence and facilitates a faster, more efficient recovery process. Robotic-assisted systems play a crucial role in restoring motor functions and improving quality of life for patients undergoing neurorehabilitation.

What Are Latest Mergers And Acquisitions In The Rehabilitation Robotics Market?

In August 2023, ReWalk Robotics, a US-based medical device company that develops and markets advanced technologies for people with neurological conditions, acquired AlterG for $19 million. The acquisition is expected to expand access for patients to innovative rehabilitation technologies for use in clinics and at home. AlterG is a US-based manufacturer of mobility enhancement products for use in physical and neurological rehabilitation.

Regional Outlook

North America was the largest region in the rehabilitation robotics market in 2025. North America is expected to be the fastest-growing region during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Rehabilitation Robotics Market?

The rehabilitation robotics market consists of sales of treadmill gait trainers, foot-plate-based gait trainers, and overground gait trainers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.